Qnexa
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Vivus has resubmitted its New Drug Application (NDA) for Qnexa (phentermine/topiramate) to FDA.
Despite high safety hurdles and a history of failure in the field, some drug firms remain cautiously optimistic for the next wave…
FDA Pipeline Preview, November 2010 (Qnexa, Linjeta, JZP-6, Bydureon, Zalbin, Staccato loxapine, Tapentadol extended-release oral analgesic, AVP-21D9, 1% tenofovir vaginal gel, AFM 13, hGH-CTP… Recent FDA action (through, October 2010) related to Qnexa, Linjeta, JZP-6, Bydureon, Zalbin, Staccato loxapine, Tapentadol…
The US FDA has accepted the VIVUS, Inc. (CA,USA) drug application for Qnexa for the treatment of obesity. The FDA aim to complete…